One consideration is that the pro‐nociceptive ligands being produced during tumour progression and leading to generation of pain signals (e.g., nerve growth factor, endothelin‐1, prostaglandin E2, etc.)may also be promoting aggressive tumour behaviours.6, 7. This evidence concerns the gene NGF and neoplasm.